DFPG Investments’s TherapeuticsMD TXMD Stock Holding History

DFPG Investments’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-200	Closed	-$3K	–	175
2022 Q1	$3K	Hold	200	–	–	﹤0.01%	168
2021 Q4	$3K	Hold	200	–	–	﹤0.01%	179
2021 Q3	$7K	Hold	200	–	–	﹤0.01%	182
2021 Q2	$11K	Hold	200	–	–	﹤0.01%	172
2021 Q1	$14K	Hold	200	–	–	0.01%	157
2020 Q4	$13K	Hold	200	–	–	0.01%	161
2020 Q3	$17K	Hold	200	–	–	0.01%	168
2020 Q2	$15K	Hold	200	–	–	0.01%	172
2020 Q1	$9K	Hold	200	–	–	0.01%	154
2019 Q4	$26K	Hold	200	–	–	0.02%	161
2019 Q3	$36K	Hold	200	–	–	0.03%	157
2019 Q2	$26K	Hold	200	–	–	0.02%	163
2019 Q1	$50K	Hold	200	–	–	0.05%	137
2018 Q4	$38K	Buy	+200	New	+$48.8K	0.05%	119

Other funds holding TXMD

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

DFPG Investments's TXMD Position: Q2 2022 in Review

DFPG Investments sold out of TherapeuticsMD (TXMD) in Q2 2022, closing a stake of 200 shares — an estimated $3K sold.

DFPG Investments first reported a position in TXMD in Q4 2018 and held it in 14 quarters. The position peaked at $50K in Q1 2019. 53 funds tracked by Wall St. Rank hold TXMD as of Q2 2022.

DFPG Investments reported no remaining TherapeuticsMD position as of Q2 2022 after selling out during the quarter.
DFPG Investments sold 200 TherapeuticsMD shares in Q2 2022, an estimated $3K.
DFPG Investments first reported a position in TherapeuticsMD in Q4 2018 and held it in 14 quarters.
DFPG Investments's TherapeuticsMD position peaked at $50K in Q1 2019.
53 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2022.

Based on DFPG Investments's 13F filing for Q2 2022, filed 1 Aug 2022.